CI Global Health Sciences Corporate Class

Series E CAD
 

Fund overview

This fund invests primarily in equity and equity-related securities of companies around the world that specialize in the health care or medical industry.

Fund details

description of elementelement value
Inception date August 2015
CAD Total net assets ($CAD)
As at 2024-10-30
$164.9 million
NAVPS
As at 2024-12-02
$8.8351
MER (%)
As at 2024-03-31
2.22
Management fee (%) 1.88
Asset class Sector Equity
Currency CAD
Minimum investment $100,000 initial/$5,000 additional
Distribution frequency Quarterly
Last distribution $0.1452

Risk rating1

  • Low
  • Low to medium
  • Medium
  • Medium to high
  • High

FUND CODES

E 16005
A ISC 201
DSC SO* 701
LL SO 1701
EF 15005
F 224
I 886
O 18005
P 90024
*No new purchases directly into switch only funds.

Performance2 As at 2024-11-30

Growth of $10,000 (Since inception date)

growth of 10k graph

Calendar year performance

annual performance graph

average annual compound returns

YTD 1 Mo 3 Mo 6 Mo 1 Y 3 Y 5 Y 10 Y Inception*
7.15% -3.59% -5.40% 0.63% 10.84% 3.05% 6.72% - 1.01%
*Since inception date

Distribution history3

Payable date Total
2022-03-25 0.1452
2021-03-26 0.0504
2020-12-18 0.0816
2020-09-25 0.0812
2020-06-26 0.0607
Payable date Total
2020-03-20 0.1493
2019-12-13 0.0857
2019-09-27 0.0962
2019-06-21 0.0906
2019-03-22 0.1450

CI PREFERRED PRICING4

Investment amount Combined fee reduction
$100,000 - $250,000 0.00%
$250,000 - $500,000 0.03%
$500,000 - $1,000,000 0.08%
$1,000,000 - $2,500,000 0.18%
$2,500,000 - $5,000,000 0.23%
$5,000,000 and above 0.30%

Management team

First we'll display the Team Company and then the Team members
Greg Quickmire
Peter Hofstra

CI Global Health Sciences Corporate Class

Series E CAD
 
Portfolio allocations5 As at 2024-10-31
Asset allocation (%)
  • US Equity 80.91
  • International Equity 18.51
  • Cash and Equivalents 0.58
Sector allocation (%)
  • Healthcare 96.10
  • Exchange Traded Fund 2.33
  • Consumer Services 0.99
  • Cash and Cash Equivalent 0.58
Geographic allocation(%)
  • United States 81.37
  • Denmark 7.80
  • United Kingdom 6.47
  • Germany 2.71
  • Switzerland 1.58
  • Canada 0.07
Top holdings
Sector (%)
1. UnitedHealth Group Inc Healthcare Services 10.74%
2. Eli Lilly and Co Drugs 10.67%
3. Novo Nordisk A/S Cl B Drugs 6.85%
4. AstraZeneca PLC Drugs 6.45%
5. AbbVie Inc Drugs 5.53%
6. Merck & Co Inc Drugs 5.48%
7. Zoetis Inc Cl A Drugs 5.14%
8. Thermo Fisher Scientific Inc Healthcare Equipment 4.01%
9. Boston Scientific Corp Healthcare Equipment 3.92%
10. Intuitive Surgical Inc Healthcare Equipment 3.61%
11. Cigna Corp Healthcare Services 3.37%
12. Anthem Inc Healthcare Services 2.90%
13. Abbott Laboratories Healthcare Equipment 2.74%
14. Stryker Corp Healthcare Equipment 2.72%
15. Siemens Healthineers AG Healthcare Equipment 2.71%
Over 35,000 financial advisors have chosen CI Global Asset Management as a partner. We believe that Canadians have the best opportunity for investments success by using the services of a professional financial advisor. Learn more at ci.com.